Call for Abstract

4th International Conference on Clinical & Experimental Dermatology, will be organized around the theme “Advanced Therapeutic and Modern Dermatological Technologies”

Dermatology-2014 is comprised of 15 tracks and 82 sessions designed to offer comprehensive sessions that address current issues in Dermatology-2014.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Acne
  • Track 1-2Skin cancer & malignancy of epithelial cells
  • Track 1-3Aging & wrinkles in ethnic skin
  • Track 1-4Contact dermatitis
  • Track 1-5Kawasaki syndrome
  • Track 1-6Cutaneous disorders
  • Track 1-7Hemangiomas & vascular malformations
  • Track 1-8Insect-related diseases
  • Track 1-9Pigmentation disorders
  • Track 1-10Psoriasis
  • Track 1-11Inflammation, scars & rashes
  • Track 1-12Vitiligo
  • Track 1-13Viral skin diseases
  • Track 2-1Geriatric dermatology
  • Track 2-2Dermapathology
  • Track 2-3Dermatological drug development
  • Track 2-4Sulfapyridine & sulfone
  • Track 2-5Case studies in dermatology
  • Track 2-6Evidence based-case sudies
  • Track 3-1Pediatric dermatology
  • Track 3-2Photoaging: Prevention & treatment
  • Track 3-3Stem cells in dermatology
  • Track 3-4Laser therapy & radiation therapy
  • Track 3-5Pathophysiology & treatment of rosacea
  • Track 4-1In-vivo studies of skin disorders
  • Track 4-2Novel procedure for the development of typically applied substances
  • Track 4-3Development of retenoids in experimental dermatology
  • Track 4-4Translational dermatology in drug discovery
  • Track 4-5Alternative therapies for veterinary dermatology
  • Track 4-6Evidence based-case study
  • Track 4-7Novel & advanced therapies in veterinary dermatology
  • Track 4-8Laser scanning microscopy
  • Track 4-9Dermoscopy & cutaneous oncology
  • Track 4-10Polarization imaging: Tissue optics
  • Track 5-1Veterinarian allergy
  • Track 5-2Insect allergy testing & treatment
  • Track 5-3Food allergy testing & treatment
  • Track 5-4Drug allergy testing & treatment
  • Track 5-5Cosmetic allergy testing & treatment
  • Track 5-6Allergy in twin pairs
  • Track 5-7Occupational allergic disorders diagnosis & treatment
  • Track 5-8Immunotherapy
  • Track 5-9Pollen allergies
  • Track 6-1Advanced approach to pediatric dermatology
  • Track 6-2Treatment & diagnosis of pediatric atopic dermatitis
  • Track 6-3Trends in pediatric patients treated for inflammatory skin diseases
  • Track 6-4Treatment & diagnosis of pediatric melanoma
  • Track 6-5Treatment & diagnosis for skin diseases with birth
  • Track 6-6Treatment & diagnosis for warts and vitiligo
  • Track 7-1 Laser treatment procedures in cosmetic dermatology
  • Track 7-2Soft tissue augmentation
  • Track 7-3Cosmetic dermatology for ethinic skin
  • Track 7-4Legal issue in cosmetic dermatology
  • Track 7-5 Novel & advanced techniques in facial cosmetic enhancement
  • Track 7-6Advancements in cosmetic surgery
  • Track 7-7Sclerotherapy
  • Track 7-8 Risk involved in breast cosmetic surgery
  • Track 7-9Sun-induced premature skin ageing
  • Track 7-10Advancements in mastoplasty techniques
  • Track 8-1Cell culture in skin-toxico pharmacology
  • Track 8-2In vitro skin-toxico pharmacological models
  • Track 8-3Treatment & diagnosis of erytema toxicum
  • Track 8-4Treatment & diagnosis of toxoplasmosis
  • Track 8-5Nano materials penetration in treatment of skin disorders
  • Track 8-6Plasminogen activators and inhibitors
  • Track 8-7Skin organ cultures
  • Track 8-8Cutaneous barrier dysfunction
  • Track 9-1Psychopharmacological therapies
  • Track 9-2Treatment & diagnosis of psycho-cutaneous disorders
  • Track 9-3Suicide risk in skin disorders
  • Track 9-4Biological tests in psychiatric
  • Track 9-5Eco-psychiarty
  • Track 9-6Psychiatric nursing
  • Track 10-1Pediatric melanoma
  • Track 10-2Skin cancers¬†after organ transplantation
  • Track 10-3 Non-melanoma skin cancer
  • Track 10-4Human Melanoma
  • Track 11-1Labelling issues & recommendations for consumers
  • Track 11-2Drug development & approvals
  • Track 11-3Ethics in cosmetic dermatology
  • Track 11-4Current regulatory status of cosmetics
  • Track 11-5Clinical practice guidelines in dermatology